Phytocannabinoids—A Green Approach toward Non-Alcoholic Fatty Liver Disease Treatment
Abstract Non-alcoholic fatty liver disease (NAFLD) is the most frequent chronic liver disease in adults in developed countries, with a…
Abstract Non-alcoholic fatty liver disease (NAFLD) is the most frequent chronic liver disease in adults in developed countries, with a…
Abstract The endocannabinoid system (ECS) is a lipid cell signaling system involved in the physiology and homeostasis of the brain…
Abstract The recent legalization of Cannabis sativa L. in many regions has revealed a need for effective propagation and biotechnologies…
Abstract Late-life mild cognitive impairment and dementia represent a significant burden on healthcare systems and a unique challenge to medicine…
Abstract Neonatal hypoxic-ischemic (HI) brain injury is one of the major drawbacks of mortality and causes significant short/long-term neurological dysfunction…
Abstract Cannabis sativa L. turned out to be a valuable source of chemical compounds of various structures, showing pharmacological activity.…
Abstract Clinical reports of cannabis use prevalence during pregnancy vary widely from 3% to upwards of 35% in North America;…
Abstract Autism spectrum disorder (ASD) is comprised of several conditions characterized by alterations in social interaction, communication, and repetitive behaviors.…
Abstract Background: Recent work has shed light on the potential benefits of cannabinoids for multimodal pain control following orthopedic procedures.…
Abstract There have been growing concerns about the protracted effects of cannabis use in adolescents on emotion and cognition outcomes,…